Affordable Inhalers and Nebulizers Act of 2025
Latest action · Sep 10, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedSep 10, 2025
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Cosponsors 13
Members who signed on, in the order they did. Signatures ran from Sep 10, 2025 to Oct 10, 2025; 11 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MD | April McClain Delaney | Original | Sep 10, 2025 |
| D-LA | Cleo Fields | Original | Sep 10, 2025 |
| D-IL | Danny K. Davis | Original | Sep 10, 2025 |
| D-DC | Eleanor Holmes Norton | Original | Sep 10, 2025 |
| D-MD | Glenn Ivey | Original | Sep 10, 2025 |
| D-GA | Henry C. "Hank" Johnson, Jr. | Original | Sep 10, 2025 |
| D-MD | Johnny Olszewski, Jr. | Original | Sep 10, 2025 |
| D-NJ | LaMonica McIver | Original | Sep 10, 2025 |
| D-MD | Sarah Elfreth | Original | Sep 10, 2025 |
| D-AL | Shomari Figures | Original | Sep 10, 2025 |
| D-MI | Shri Thanedar | Original | Sep 10, 2025 |
| D-NC | Valerie P. Foushee | Sep 26, 2025 | |
| D-MA | Stephen F. Lynch | Oct 10, 2025 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Sep 10, 2025 |
| House | Ways and Means Committee | Referred Sep 10, 2025 |
| House | Education and Workforce Committee | Referred Sep 10, 2025 |
Actions 2
Everything that happened, newest first.
- Sep 10, 2025Introduced in House
- Sep 10, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 148, September 10, 2025, page H4239.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2756 | Affordable Inhalers and Nebulizers Act of 2025 | Related bill | Sep 10, 2025 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to reduce patient cost sharing for prescription drug inhaler products used to treat breathing disorders such as asthma and chronic obstructive pulmonary disease, and for other purposes.
- Short Title(s) as Introduced
- Affordable Inhalers and Nebulizers Act of 2025
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Sep 10, 2025Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.